Alimera Sciences, Inc.
ALIM · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $81 | $54 | $59 | $51 |
| % Growth | 49.2% | -8.3% | 16.2% | – |
| Cost of Goods Sold | $20 | $8 | $7 | $7 |
| Gross Profit | $61 | $46 | $52 | $44 |
| % Margin | 75.7% | 85.3% | 88.1% | 86.3% |
| R&D Expenses | $17 | $16 | $14 | $10 |
| G&A Expenses | $19 | $13 | $13 | $12 |
| SG&A Expenses | $46 | $39 | $36 | $32 |
| Sales & Mktg Exp. | $28 | $26 | $23 | $20 |
| Other Operating Expenses | $0 | $3 | $3 | $3 |
| Operating Expenses | $63 | $58 | $52 | $44 |
| Operating Income | -$2 | -$12 | -$0 | -$1 |
| % Margin | -2.4% | -21.5% | -0.3% | -1% |
| Other Income/Exp. Net | -$18 | -$6 | -$4 | -$5 |
| Pre-Tax Income | -$20 | -$18 | -$4 | -$5 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$20 | -$18 | -$4 | -$5 |
| % Margin | -24.9% | -33.5% | -7.4% | -10.5% |
| EPS | -0.79 | -2.59 | -0.66 | -1.04 |
| % Growth | 69.5% | -292.4% | 36.5% | – |
| EPS Diluted | -0.79 | -2.59 | -0.66 | -1.04 |
| Weighted Avg Shares Out | 26 | 7 | 7 | 5 |
| Weighted Avg Shares Out Dil | 26 | 7 | 7 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $10 | $6 | $5 | $5 |
| Depreciation & Amortization | $9 | $3 | $3 | $3 |
| EBITDA | -$1 | -$9 | $4 | $3 |
| % Margin | -1.4% | -17.5% | 6.9% | 5.2% |